ARTICLE | Clinical News
Aradigm regulatory update
September 30, 1996 7:00 AM UTC
ARDM received U.S. Patent No. 5,558,085 covering its method of delivering peptide-based drugs via inhalation. The method is a key component of the company's AERx Pulmonary Drug Delivery System and is ...